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PART ONE
“It is a bad plan that admits of no modification.”
- Publius Syrus (42 B.C.) Bartlett, 2000)
Introduction
“How wrong I was!” This admission from John H. Young (Young, 2006, p. 340) relates
to his first exposure to pharmaceutical marketing more than 20 years ago. Young states he had
been “sent to represent the medical group at a planning meeting of the launch of a new nonsteroidal.” He felt competent he could hold his own at the meeting.
At the planning meeting, however, as competition, inventories, market segments,
inventories, formulation issues, opinion leader development, and public relations campaigns
highlighted discussions, Young learned he would out of his depth. He needed to, Young
determined, learn about marketing and production as quickly as possible – before the next
planning meeting.
The policy for marketing pharmaceuticals, like that for many global markets, is highly
complex. Unlike most global industries, however, the pharmaceutical industry is highly
fragmented. (Ibid. p. 342) In a similar sense, planning for pharmaceutical promotional meetings
frequently proves to be disjointed, with individuals who work as marketing planners, at times,
like Young, getting out of their depth.
Strategic Planning for a Buoyant, Yet Rigid Market
Young (Ibid. p.343) stresses that the value of marketing to a product’s success cannot be
underestimated. A marketing plan, which includes promotional meetings, needs to be wellthought out, executed, as well as, constantly revised and/or modified.
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An increasingly competitive buoyant, yet rigid and regulated marketplace requires
strategically planned, exceptional meetings to help accomplish key business objectives.
Consequently, pharmaceutical companies have turned to promotional breakfast, lunch and dinner
meetings where a select number of healthcare professionals, such as Young, are invited. During
the course of these meetings, an approved speaker (trained by the pharmaceutical company)
reports on a generic topic that relates to the particular product(s) the pharmaceutical company
sells.
In his/her quest to sell particular products, the pharmaceutical sales representative (either
by region or district) initiates the meeting which a meeting planner then plans. The meeting,
attended by the representative, speaker and healthcare professionals must adhere to government
rules and regulations. A few of the requirements a promotional meeting must adhere to include
the amount of money spent on each person attending, speakers’ fees and the minimum number of
individuals needed to successfully support/attend an event.
When planning promotional meetings, to fulfill requirements and ensure adherences to
rules, regulations and requirements, a meeting planner needs to answer a number of questions.
The number one could be: Can a pharmaceutical company comply with current challenging
constraints to planning a breakfast/lunch/dinner promotional meeting?
Another question deserving an appropriate assessment could be: How can a
pharmaceutical company effectively plan and implement a “successful” pharmaceutical
breakfast/lunch/dinner promotional meeting, yet simultaneously comply with the combined,
constantly-changing company and government pharmaceutical rules and regulations?
An appropriate answer to both questions would be: A pharmaceutical company not only
can, but must effectively plan and implement a “successful” pharmaceutical
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breakfast/lunch/dinner promotional meeting, while simultaneously complying with the
combined, constantly-changing company and government pharmaceutical rules and regulations!
Currently, “human” planners ensure the myriad of equipment, employee and attendee
specifications are delivered and/or set up in place to fill the “clients need to produce a smooth
running event or meeting.” (Event Partners, 2005) As more and more and more rigorous
regulations, full-fledged, federal scrutiny, pricing pressures and a tarnished public image
incessantly inhibit the meeting planning industry, in addition to the human touch, the need for an
all-inclusive promotional pharmaceutical meeting planning clamors to be heard. During the
course of this professional paper, I have related concepts to meet the criteria for the creation and
development of PharmaSalve (PS) software, an innovative answer to this pressing need.
Purpose
The phrase “problem definition” proves particularly important in that it simply states the
situation being discussed and rectified in this professional paper. The entire process and sections
of the paper are based on this definition. To resolve a specific problem of compliance and
pharmaceutical meeting planning, the ideal outcome would be the development of software that
can obtain all compliance rules and regulations needed for each client and use these during the
meeting planning process. For example, seventy-two hours before the event the client states,
“The sales rep has to have at least 3 attendees RSVP for the dinner meeting or the meeting is
automatically cancelled.”
At the designated time, seventy-two hours prior to the start time, the software program
analyzes this particular meeting and informs the meeting planner the program does not meet all
conditions to this rule and consequently, the meeting is cancelled. PS: The software can also be
set to automatically send the cancellation notice to the involved parties (i.e. planner, rep and

7

district managers). This software would also need to include a user-friendly formula whereby
compliance issues and rules may easily be easily updated, if necessary, even hour by hour.
To begin to fill the pressing need for software such as PS, current criteria for government
compliance was explored as well as client needs and meeting planner’s objectives. As the
researcher, I investigated government and pharmaceutical companies’ requirements, along with
those of the meeting planner.
Next, along with securing internal advisements from current industry employees and
external information from reliable and scholarly sources, I accessed more than 20 publications.
Ultimately, to support this study venture, I must conclude that the necessary data needed to fulfill
this study’s projected plan, to lay the foundation to create and develop PPMP software, to assist
client needs in the aspect of promotional meeting planning proves “perfected.” The PS software,
as suggested by the introductory quote, remains open to positive modifications.
The following specific research objectives, which evolved in response to my quest to
arrive at destination PS, are met during the course of completing this professional paper:
Objective 1
Identify government/company compliance rules and regulations mandated for
promotional breakfast/lunch/dinner pharmaceutical meetings.
Objective 2
Determine correspondence and reporting needs, regarding rules and regulations from
objective one, needed to achieve a successful event, which a meeting planner needs to
communicate to:
a. The client,
b. The venue,
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c. To speaker, and
d. To sales representatives.
Objective 3
To develop software with the ability, as well as vital tools, to host all rules, regulations,
dollars and databases to create a complete system for the company and the meeting planner.
Objective 4
To assess costs in savings to companies, gained from utilizing a more efficient alternative
possessing the ability to empower meeting planners to become more productive; reporting results
in less time.
Justification
When contemplating criteria to convey support for PS, my mind returned to challenges
continually confronted when associated with Advogent. During this particular, employment
tenure, issues repeatedly arose with client compliance, office operations and communication,
which ultimately intensified and culminated myself resigning my position after two and a half
months on October 31, 2007. Consequently, I determined to relate these issues in writing as they
may easily be resolved and, in turn, improve the working environment, while simultaneously
contributing to employee retention.
Contrary to components contributing to the concept of retention, Advogent’s record of
repeatedly being transferred by a number of buyouts (i.e. Cardinal Health) turned the entire
pharmaceutical marketing process inside out. Without solid, leading guidelines, the office
routine fell by the wayside, leaving employees to deal with a myriad of confusing choices on
their own. In addition, experiencing a dearth in the number of employees needed to complete
necessary work additionally complicated Advogent’s situation.
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Client Compliance
As Project Manager for meeting planning on the Abbott Humira team, I repeatedly
encountered challenges connected with compliance issues. It seemed that not one sentence could
be spoken with the word “compliance” tangled somewhere in-between words and phrases.
“Get it in writing.”
“Get it approved.”
“Show proof.”
“Keep hard copies of everything.”
“Record all conversation notes.”
“Get all the required back-up.”
These phrases comprise everyday lingo when it comes to planning promotional meetings
for the Humira Sales Representative. My previous manager, in contributing to ensuring client
compliance in planning marketing meetings, efficiently organized her team, and simultaneously
created conscientious checklists to ensure that I and other team members crossed all the
necessary “ t’s” and doted all the vital “i’s”.
This subject of client compliance continually compels me, due to personal involvement in
numerous audits and constant checks of the planning program coordinators’ files and programs.
If one could not prove what he/she proposed, he/she did not get paid. Simple.
Office Operations
From the disproportionate turnover and owner change rate represented in planning
programs, I purports that the company’s entire operations constitute a “mess”. As interesting as
this topic appears to me, I choose not to focus on this concern, however, since it involves three
offices (east coast, west coast and the mid-west). With every company being unique, I perceived
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that no cookie cutter technique exists to fix these types of problems. During the two and half
months, I noted the company employing me changed owners once and the organizational
structure five times!
In time, the company hired an “expert” to restart the company; to reassess all records, as
well as, each and every person. A number of employees related they were worried about their
jobs. This concern contributed immensely to my decision to leave this particular position.
Communications
What organized company does not have a distribution list for all employees? For the
mid-west office, this company has not yet created a simple distribution list to simultaneously
send emails to the entire office for informational emails and meeting requests. My name has
repeatedly been left off meeting requests because an individual forgot to add my name, as the
newest employee, to the email.
Several times in the past, the 20+ employees would be sitting in the conference room,
attending an informal meeting when I walked by to check the fax machine. In passing, I then
peered into the room, silently questioning, “Are we having a meeting”? Unfortunately, the
absurd truth regarding this scenario only depicts the beginning of the problems associated with
the communication for the office.
As the pharmaceutical meeting planning industry is inhibited by the ever-changing
compliance and reporting needs of their pharmaceutical clients, the PS software will assist this
industry specific meeting planning companies in client management. In turn, meeting planning
companies can more readily meet company specific goals. Less client turnover will prove to be
an additional benefit from using PS software. The ability to house all vital data in one location
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embodying specific bits of information the client needs will prove to contribute positive results
and higher revenue for all parties involved.
Constraints
Self-imposed constraints constitute the only currently recognized inhibitor to the final
development of the PS software. A dearth of applicable funds to invest in the PS platform makes
the full-fledged development of the dream software unattainable at this time. The final step in
this professional paper presents the intact blueprint and associated research to assist in software
development. This study concludes with the hopes of one day securing partners and investment
dollars for PS. PS constitutes a solid, salient creation that will revolutionize the medical meeting
planning industry.
The following figure (1) depicts the perception of PS, the ultimate meeting planner
software, which according to Publius Syrus’s measurement, depicts a good plan, open to
modifications.

Figure 1 - Perception of PS, the ultimate meeting planner software
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PART TWO
“...Where no plan is laid, where the disposal of time is surrendered merely to the chance
of incidents, all things lie huddled together in one chaos, which admits neither of distribution nor
review.” Hugh Blair (1718–1800) (Respectfully Quoted, 2003).
Laying Plans
“The marketing strategies of the world's biggest drug companies now aggressively target
the healthy and the well.” (Moynihan & Cassels, 2005, p. ix) This bold statement reflects one
primary challenge pharmaceutical companies currently contend with, which, in turn, challenges
pharmaceutical marketing planners to, when planning promotional meetings, target
Key Dynamics
During 2007, the global pharmaceutical market which grew 6 - 7 percent is predicted to
grow at a 5 - 6 percent pace in 2008. In its 2008 forecast, IMS, world’s leading provider of
market intelligence to the pharmaceutical and healthcare industries, identifies a number of key
market dynamics, of which the following depicts a few:
•

Growth contribution from top seven markets falls. In the U.S. and the five largest
European markets, sales growth in 2008 is expected to range from 4 - 5 percent.
This marks a historic low for the U.S. Japan market growth is forecast to grow 1 2 percent next year, down from the 4 - 5 percent pace expected in 2007…. .

•

“Pharmerging” market growth accelerates. The seven “pharmerging” markets of
China, Brazil, Mexico, South Korea, India, Turkey and Russia are expected to
grow 12 - 13 percent next year, to $85 - 90 billion…. Ongoing economic growth
in the developing world will continue to shift the focus away from infectious
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diseases and toward cardiovascular, diabetes and other chronic
illnesses.………………………………
•

Implications for Pharmaceutical, Biotech and Generics Manufacturers

“These indicators paint the stark reality of a marketplace in transition,” said Aitken. “The
actions being taken by companies to reinvent themselves will need to continue at an accelerated
pace. Today, commercial strategies and tactics are being re-assessed to better align with future
opportunities, while portfolio strategies are being adjusted to capture growth in emerging
markets and reflect shifts in product values. In this market environment, building relationships
directly with patients as they become better educated and take a more active role in their own
healthcare also is essential. And, the industry must continue engaging the broader healthcare
community in a rational and positive dialogue about the delivery of higher-quality healthcare to
patients at lower cost.”
Examining the Contemporary, Critical Concern
PS effectively fills the need for pharmaceutical promotional meeting planning
software to provide a “simple”, salient solution for contemporary, critical concerns in planning
marketing meetings. PS software will assist in employee efficiency, as it provides the tools
necessary to create a more professional internal environment. Consequently, PS will contribute
to the cultivation of more satisfied clients and less client turnover. Another benefit to PS,
internal to the company, will be the better service employees provide, as PS contributes to
employees experiencing more confidence in their work. During client interactions, the client
will note the higher employee morale PS produces.
Measurement
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Measurement is the process observing and recording the observations that are collected as
part of a research effort. There are two major issues that will be considered here.
First, you have to understand the fundamental ideas involved in measuring. Here we
consider two of major measurement concepts. In Levels of Measurement, I explain the meaning
of the four major levels of measurement: nominal, ordinal, interval and ratio. Then we move on
to the reliability of measurement, including consideration of true score theory and a variety of
reliability estimators.
Second, you have to understand the different types of measures that you might use in
social research. We consider four broad categories of measurements. Survey research includes
the design and implementation of interviews and questionnaires. Scaling involves consideration
of the major methods of developing and implementing a scale. Qualitative research provides an
overview of the broad range of non-numerical measurement approaches. And unobtrusive
measures presents a variety of measurement methods that don't intrude on or interfere with the
context of the research. (Trochim, 2006)
Construct Validity
In explaining construct validity, which denotes the degree from which inferences may be
legitimately developed from the operationalizations in a study to the theoretical constructs on
which those operationalizations were based. Trochim (2006) divides the issues into two broad
territories, as he purports this helps some individuals:
1.

The "land of theory", consists of mental strategy; ideas; hunches; hypothesis
about world. The land of theory depicts what occurs inside a person’s
mind and his/her effort to explain or articulate this to others.
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2.

The "land of observation” constitutes what a person sees happening in the world
around him/her, along with the public manifestations of that world. In the
land of observation, an individual discovers his/her actual program or
treatment; actual measures or observational procedures. (Trochim, 2006)

Trochim’s (2006) admonition for a researcher to construct the land of observation based
on his/her theories. In turn, I developed the concept for PS to reflect my “land of theory.”
(Trochim, 2006)

In the testing realm, Likert Scaling proves to be more popular than a number of other
scaling systems because it is easier. (Dunn-Rankin, Knezek, Wallace & Zhang, 2004, p. 105)
Likert (1932) argued that:
1.

category intervals are generally equal;

2.

category labels can be preset subjectively and
16

3.

the judgment phase of creating a scale can be replaced by an item analysis
performed on the results of the respondents’ responses.

Likert’s arguments contend that in Likert scaling, the strength of a person's preference
about all the psychological objects replaces the direction and intensity of the specific objects that
a respondent would have judged. Successive Interval Scaling and Likert Scaling, when carefully
applied, often yield similar results. The best way to measure construct(s) is by using the Likert
Scale. Consequently, the following survey was developed to interview employees and help
determine how these individual perceive the need for an all inclusive meeting planning software
for promotional meetings by pharmaceutical meetings.
Surveys
Surveys can be divided into two broad categories: the questionnaire and the interview.
Questionnaires are usually paper-and-pencil instruments that the respondent completes.
Interviews are completed by the interviewer based on the respondent says. Sometimes, it's hard
to tell the difference between a questionnaire and an interview. For instance, some people think
that questionnaires always ask short closed-ended questions while interviews always ask broad
open-ended ones. But you will see questionnaires with open-ended questions (although they do
tend to be shorter than in interviews) and there will often be a series of closed-ended questions
asked in an interview. (Trochim, 2006)
Directions to survey participants: Please indicate your agreement or disagreement
with each statement by checking the appropriate numbered box to indicate whether you:
1 - Strongly Agree
2 - Agree
3 - Neutral
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4 – Disagree
5 - Strongly Disagree
1. Client compliance surfaces as a constant issue in my job.
2. Client compliance varies from client to client.
3. Changes and additions to client compliances can occur each day.
4. In regard to compliance issues, constant, sometimes daily, email and phone
communication occurs.
5. Regarding approved speakers, routine, sometimes daily, email and phone communication
must occur.
6. Any meeting with a compliance issue must be routed throuh an approval process.
7. In regard, to question number 6, this approval process consists of a myriad of steps.
8. I am constant communicating with my manager and/or client regarding compliance
issues.
9. Many steps are involved in the process of planning a promotional meeting.
10. Current procedures to perform my job are very inefficient.
11. Too much of my time is spent completing administrative work that could be streamlined.
12. There are too many documents and spreadsheets I have to update daily (sometimes
hourly) which can easily result in errors.
13. I could be work more efficiently and be a better meeting planner if I did not have to make
appearances in so many locations to obtain and/or update information for each meeting.
14. My company loses money and wastes valuable time, due to inefficient practices related to
planning meetings.
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15. My company could easily correct a number of problems related to planning meetings if a
software program existed to host all the necessary documents, reports and at a bases
needed to plan a promotional meeting.
16. Employee morale related to planning meetings is sometimes low.
17. Employee morale would likely improve if a meeting planner software program were
available.
18. I do not feel my company perceives my worth due to the inefficient way a number of
procedures are currently run.
19. If given the right tools, I can be much more productive in my position.
20. I would like to excel in my position.
Software Considerations
Preventing problems that could threaten the effectiveness of software, according to
Piazza (2005, p. 39) makes more sense than doing what car manufacturer sometimes do, rush a
new model to market and then find a problem exists. Ramifications such as security and other
potential glitches software sometimes experiences have to be considered.
Although software vendors do not typically recall their products when security holes or
other glitches surface; rather, but send out patches and updates, each time this occurs denotes a
reminder that the original work was not done right. Kenneth R. van Wyk, coauthor of the book
Secure Coding: Principles and Practices, questions: “….Why is it so hard to write secure code in
the first place?” (Piazza, 2005)
Wyk answers his own question, noting: "Software developers develop 'functional
spec….They're told to write a piece of software that does this and that, but they're not really good
at considering security ramifications, such as imagining how someone could deliberately and
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maliciously misuse the application.” (Piazza, 2005)
Ted Julian, vice president of marketing for AppSecInc purports that anticipating
problems in software, “…more often than not, I suspect it's a judgment call….because it depends
on how [a] function is used within the context of the broader application. Whether or not what
appears to be an issue is an issue at all, or how severe an issue is, is not an easy thing to
automate."
“Under normal circumstances,” Wagner (2006, p. 8) notes, regarding times when
decisions have to be made in stressful situations, “team members can readily gather and share the
information they each need to make a decision and develop an appropriate response to problems.
But in situations where there is no time to get the needed information and reason out a response,
team performance suffers--and so do decisions (and outcomes).” According to Wagner (2006, p.
8) decision-making software system developed for military applications could help human
partners make the right decisions at the right time, particularly when they are “under fire.”
The Power of Software
To see why software is similar to physical architecture but profoundly more
powerful, we need to examine how software is written and used. The story begins with a
programmer who has in mind some task she would like a computer to carry out. She attempts to
envision as precisely as possible the details of the process by which she would like that task
carried out. This precision is necessary because she must express her intention in the text of a
computer program--a list of instructions, written in one of a number of artificial languages
intelligible to a computer. Compared with human languages, these languages are highly
constrained. Each of her instructions carries a fixed and precise meaning. Once she has finished
editing the program, her role ends. She turns the program over to the computer on which it will
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run. As long as the computer is supplied with power and is free of mechanical and electronic
glitches, it will read her instructions and carry them out. A user may now encounter the program-that is, be regulated by it. This encounter has an important dual quality. On the one hand, the
software enables functionality. When I type in a chat room and my words appear on your screen,
this communication has been enabled by the chat program, which in turn reflects the
programmer's design decisions. Without her program, the communication could not happen. On
the other hand, software also limits behavior (Grimmelamnn, 2005).
Drug companies struggle with balancing pressing health needs and return on investment
demands (Agres, 2007)
John MacCarthy, IMS' head of client thought leadership group, told The Financial Times.
The average difference between countries where a drug sold best and where it sold worst was
26%, indicating that modifying marketing strategies to fit local factors was essential to boosting
sales.
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PART THREE
“You can never plan the future by the past.”
- Edmund Burke (1729–1797) (Columbia)
In the First Place
“When you're under attack, making the right decision quickly is difficult,” Wagner (2006,
p. 8) stresses, “no matter how well trained your team is.” Wagner’s contention that a military
decision-making software system developed for military applications could help individuals
“under fire” make better decisions. PS will help marketing planners, contrary to practices in the
past, better plan their future pharmaceutical promotions.

Planning how to avoid and

prevent future problems constitutes not only a prime consideration for the development of PS,
but also the “guts” of this software, envisioned to serve marketing planners. As Piazza (2005, p.
39) notes, it anticipate and prepare to head off potential problems prior to their disruptions, to
prevent the problem in the first place.
Discussion
The worldwide pharmaceutical market is expected to more than double to $1.3 trillion by
2020. Along with the growth, the pharmaceutical industry faces a myriad of challenges, which
include regulatory uncertainty, anemic pipelines, investment pessimism, and diminishing public
perception. Consequently, the pharmaceutical industry worldwide stands at a crossroads. Agres
(2007) purports that “Big Pharma” needs to:
•

Address the composite changes currently occurring in the "payer landscape" as
patients, consumers, and public and private insurers more and more and more
define value for money.
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•

Obtain a better grip on safety and regulatory issues, along with seizing
opportunities in emerging economies, and challenges from developing countries.

•

Deliberately deal with "reputation management” issues, as the market holds Big
Pharma responsible for common concerns such as managing risk, predatory
pricing, , and macro-emphasizing "me-too" drug development , yet
simultaneously downplaying innovative research.

As this study examined research related to policies, procedures and current plans for
marketing pharmaceuticals and planning promotional meetings, it was found that, as projected,
these too frequently prove to be disjointed, with marketing planners, at times, becoming
overwhelmed and overworked, yet underproductive. At this time, according to research related
by current research, no rational, reasonable answer to this problem exists.
Research Objectives
The following specific research objectives, which evolved in response to the quest
to arrive at destination PS, are met during the course of completing this professional paper:
Objective 1
Identify government/company compliance rules and regulations mandated for
promotional breakfast/lunch/dinner pharmaceutical meetings.
Objective 2
Determine correspondence and reporting needs, regarding rules and regulations from
objective one, needed to achieve a successful event, which a meeting planner needs to
communicate to:
a. The client,
b. The venue,
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c. To speaker, and
d. To sales representatives.
Objective 3
To develop software with the ability, as well as vital tools, to host all rules, regulations,
dollars and databases to create a complete system for the company and the meeting planner.
Objective 4
To assess costs in savings to companies, gained from utilizing a more efficient alternative
possessing the ability to empower meeting planners to become more productive; reporting results
in less time.
Preventing Problems in the Real World
Unlike Event Partners’ (2005), as well as, a number of other businesses who market
business planning, the claim that a person or company can always host the perfect meeting,
without a glitch does not match my personal experience of the understanding gained from
completing this professional paper. Companies are not always able to empower their employees
to invest the ideal amount of time to produce quality work in the meeting planning fields. Time
constants commonly contribute to this dearth.
PS, nevertheless, will afford, allot, and/or help allocate more time for meeting planners as
this software manages, some of the currently, sometimes seemingly unmanageable details
involved in hosting marketing meetings. This study conclusively confirms this my initial
contention that PS, aka PhamaSalve, “the” answer to simplifying planning of pharmaceutical
promotional meetings is not only needed, but, will hopefully, soon be marketed to meet desired
and mandated needs.
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PS will help prevent real world problems, particularly when circumstances, as Wagner
(2006, p. 8) notes, prove stressful, during times when decisions have to be made quickly and no
time exists to obtain needed information and reason out detailed responses.
Recommendations
PS can compliment “the market” Big Pharma contends with as it will be designed to:
•

Note value patients, consumers, and public and private insurers define; include in
planning meetings.

•

Adhere to regulatory issues, and relate techniques to seize opportunities emerging
opportunities present.

•

Constructively cope with contemporary concerns; reveal challenges, while
simultaneously revealing and encouraging innovative marketing strategies.

On Target
Contrary to the point Burke notes at the start of this final chapter, that one can never plan
the future by the past, I propose that noting past problems can serve to illuminate needs and help
one more accurately aim to meet his/her goals. PS targets and effectively fills the need for
pharmaceutical promotional meeting planning software to provide a “simple”, salient solution for
contemporary, critical concerns in planning marketing meetings.
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